
Gene-corrected regulatory T cell therapy for IL2RA deficiency
Alvin S Ha, Nechama Kalter, Michael Rosenberg, Luis A Acevedo, Brianna Liang, Weihong Liu, Sreenivasan Paruthiyil, Meenal Sinha, Alexander Vu, Vinh Nguyen, Zhongxia Qi, Netravathi Krishnappa, Jinna Shu, Jingwei Yu, Jason Catanzaro, Jeffrey A Bluestone, Qizhi Tang, Fyodor D Urnov, Alexander Marson, Ayal Hendel, Kevan C Herold, Brian R Shy, Jonathan H Esensten
Molecular Therapy, 2025
Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113)
María Ortiz-Bueno, Iris Ramos-Hernández, Luis Algeciras-Jiménez, Nechama Kalter, Juan Roberto Rodríguez-Madoz, Jose Bonafont, Rajeevkumar Raveendran Nair, Oliver Feeney, Laura Torella, Lluis Montoliu, Petros Patsali, Claudio Mussolino, Yonglun Luo, Merita Xhetani, Alessia Cavazza, Ayal Hendel, Karim Benabdellah, Carsten Werner Lederer, Francisco J Molina-Estévez
Frontiers in Genome Editing, 2025
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges
Nechama Kalter, Carla Fuster-García, Alfredo Silva, Víctor Ronco-Díaz, Stefano Roncelli, Giandomenico Turchiano, Jan Gorodkin, Toni Cathomen, Karim Benabdellah, Ciaran Lee, Ayal Hendel
Molecular Therapy Nucleic Acids, 2025
Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years
Lúcia Mamede, Roser Cantenys Sabà, Samya Van Coillie, Johan Prévot, Silvia Sánchez-Ramón, Cecilia Poli, Anne Barasa, Björn W Schuller, Ayal Hendel, Nicolas Garcelon, Cornelis Boersma, Pamela Lee, Claire Booth, Luigi D Notarangelo, Jose Drabwell, Nicholas L Rider, Frank J T Staal, Martin Van Hagen, Martine Pergent, Jacques G Rivière, Nizar Mahlaoui
Frontiers in Immunology, 2025
Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells
Vasyl Eisenberg, Shiran Hoogi, Erel Katzman, Nimrod Ben Haim, Raphaelle Zur-Toledano, Maria Radman, Yishai Reboh, Oranit Zadok, Iris Kamer, Jair Bar, Irit Sagi, Ayal Hendel, Cyrille J Cohen
Cancer Immunology Research, 2024
Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells
Avishay Edri, Nimrod Ben-Haim, Astar Hailu, Nurit Brycman, Orit Berhani-Zipori, Julia Rifman, Sherri Cohen, Dima Yackoubov, Michael Rosenberg, Ronit Simantov, Hideshima Teru, Keiji Kurata, Kenneth Carl Anderson, Ayal Hendel, Aviad Pato, Yona Geffen
International Journal of Molecular Sciences, 2023
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Alessia Cavazza, Ayal Hendel, Rasmus O Bak, Paula Rio, Marc Güell, Duško Lainšček, Virginia Arechavala-Gomeza, Ling Peng, Fatma Zehra Hapil, Joshua Harvey, Francisco G Ortega, Coral Gonzalez-Martinez, Carsten W Lederer, Kasper Mikkelsen, Giedrius Gasiunas, Nechama Kalter, Manuel A F V Gonçalves, Julie Petersen, Alejandro Garanto, Lluis Montoliu, Marcello Maresca, Stefan E Seemann, Jan Gorodkin, Loubna Mazini, Rosario Sanchez, Juan R Rodriguez-Madoz, Noelia Maldonado-Pérez, Torella Laura, Michael Schmueck-Henneresse, Cristina Maccalli, Julian Grünewald, Gloria Carmona, Neli Kachamakova-Trojanowska, Annarita Miccio, Francisco Martin, Giandomenico Turchiano, Toni Cathomen, Yonglun Luo, Shengdar Q Tsai, Karim Benabdellah; COST Action CA21113
Molecular Therapy - Nucleic Acids, 2023
Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel
Atar Lev, Idan Sharir, Amos J Simon, Shiran Levy, Yu Nee Lee, Shirly Frizinsky, Suha Daas, Talia Saraf-Levy, Arnon Broides, Amit Nahum, Suhair Hanna, Polina Stepensky, Ori Toker, Ilan Dalal, Amos Etzioni, Jerry Stein, Etai Adam, Ayal Hendel, Nufar Marcus, Shlomo Almashanu, Raz Somech
Journal of Allergy and Clinical Immunology, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, Yael Aylon, Rona Yaeger, Giulia Fontemaggi, Saptaparna Mukherjee, Martino Maddalena, Adi Avioz, Ortal Iancu, Giuseppe Mallel, Anat Gershoni, Inna Grosheva, Ester Feldmesser, Shifra Ben-Dor, Ofra Golani, Ayal Hendel, Giovanni Blandino, David Kelsen, Yosef Yarden, Moshe Oren
Nature Communications, 2022
Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment
Eran Hodis, Elena Torlai Triglia, John Y H Kwon, Tommaso Biancalani, Labib R Zakka, Saurabh Parkar, Jan-Christian Hütter, Lorenzo Buffoni, Toni M Delorey, Devan Phillips, Danielle Dionne, Lan T Nguyen, Denis Schapiro, Zoltan Maliga, Connor A Jacobson, Ayal Hendel, Orit Rozenblatt-Rosen, Martin C Mihm Jr, Levi A Garraway, Aviv Regev
Science, 2022
High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus-Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells
Daniel Allen, Lucien E Weiss, Alon Saguy, Michael Rosenberg, Ortal Iancu, Omri Matalon, Ciaran Lee, Katia Beider, Arnon Nagler, Yoav Shechtman, Ayal Hendel
CRISPR Journal, 2022
CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data
Ido Amit, Ortal Iancu, Alona Levy-Jurgenson, Gavin Kurgan, Matthew S McNeill, Garrett R Rettig, Daniel Allen, Dor Breier, Nimrod Ben Haim, Yu Wang, Leon Anavy, Ayal Hendel, Zohar Yakhini
Nature Communications, 2021
Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects
Atar Lev, Yu Nee Lee, Guangping Sun, Enas Hallumi, Amos J Simon, Keren S Zrihen, Shiran Levy, Tal Beit Halevi, Maria Papazian, Neta Shwartz, Ido Somekh, Sarina Levy-Mendelovich, Baruch Wolach, Ronit Gavrieli, Helly Vernitsky, Ortal Barel, Elisheva Javasky, Tali Stauber, Chi A Ma, Yuan Zhang, Ninette Amariglio, Gideon Rechavi, Ayal Hendel, Deborah Yablonski, Joshua D Milner, Raz Somech
Journal of Experimental Medicine, 2021
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System
Jenny Shapiro, Ortal Iancu, Ashley M Jacobi, Matthew S McNeill, Rolf Turk, Garrett R Rettig, Ido Amit, Adi Tovin-Recht, Zohar Yakhini, Mark A Behlke, Ayal Hendel
Molecular Therapy - Methods & Clinical Development, 2020
CRISPR-based Gene Editing Enables FOXP3 Gene Repair in IPEX Patient Cells
M Goodwin, E Lee, U Lakshmanan, S Shipp, L Froessl, F Barzaghi, L Passerini, M Narula, A Sheikali, C M Lee, G Bao, C S Bauer, H K Miller, M Garcia-Lloret, M J Butte, A Bertaina, A Shah, M Pavel-Dinu, A Hendel, M Porteus, M G Roncarolo, R Bacchetta
Science Advances, 2020
Reduced function and diversity of T cell repertoire and distinct clinical course in patients with IL7RA mutation
Atar Lev, Amos J Simon, Ortal Barel, Eran Eyal, Efrat Glick-Saar, Omri Nayshool, Ohad Birk, Tali Stauber, Amit Hochberg, Arnon Broides, Shlomo Almashanu, Ayal Hendel, Yu Nee Lee, Raz Somech
Frontiers in Immunology, 2019
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells
M Kyle Cromer, Sriram Vaidyanathan, Daniel E Ryan, Bo Curry, Anne Bergstrom Lucas, Joab Camarena, Milan Kaushik, Sarah R Hay, Renata M Martin, Israel Steinfeld, Rasmus O Bak, Daniel P Dever, Ayal Hendel, Laurakay Bruhn, Matthew H Porteus
Molecular Therapy, 2018
Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
Sriram Vaidyanathan, Krist T Azizian, A K M Ashiqul Haque, Jordana M Henderson, Ayal Hendel, Sabrina Shore, Justin S Antony, Richard I Hogrefe, Michael S D Kormann, Matthew H Porteus, Anton P McCaffrey
Molecular Therapy Nucleic Acids, 2018
A Comprehensive TALEN-Based Knockout Library for Generating Human-Induced Pluripotent Stem Cell-Based Models for Cardiovascular Diseases
Ioannis Karakikes, Vittavat Termglinchan, Diana A Cepeda, Jaecheol Lee, Sebastian Diecke, Ayal Hendel, Ilanit Itzhaki, Mohamed Ameen, Rajani Shrestha, Haodi Wu, Ning Ma, Ning-Yi Shao, Timon Seeger, Nicole Woo, Kitchener D Wilson, Elena Matsa, Matthew H Porteus, Vittorio Sebastiano, Joseph C Wu
Circulation research, 2017
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P Dever, Rasmus O Bak, Andreas Reinisch, Joab Camarena, Gabriel Washington, Carmencita E Nicolas, Mara Pavel-Dinu, Nivi Saxena, Alec B Wilkens, Sruthi Mantri, Nobuko Uchida, Ayal Hendel, Anupama Narla, Ravindra Majeti, Kenneth I Weinberg, Matthew H Porteus
Nature, 2016
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel, Rasmus O Bak, Joseph T Clark, Andrew B Kennedy, Daniel E Ryan, Subhadeep Roy, Israel Steinfeld, Benjamin D Lunstad, Robert J Kaiser, Alec B Wilkens, Rosa Bacchetta, Anya Tsalenko, Douglas Dellinger, Laurakay Bruhn, Matthew H Porteus
Nature Biotechnology, 2015
PCNA Ubiquitination Is Important, But Not Essential for Translesion DNA Synthesis in Mammalian Cells
Ayal Hendel, Peter H L Krijger, Noam Diamant, Zohar Goren, Petra Langerak, Jungmin Kim, Thomas Reissner, Kyoo-young Lee, Nicholas E Geacintov, Thomas Carell, Kyungjae Myung, Satoshi Tateishi, Alan D'Andrea, Heinz Jacobs, Zvi Livneh
PLoS Genetics, 2011
Separate domains of Rev1 mediate two modes of DNA damage bypass in mammalian cells
Jacob G Jansen, Anastasia Tsaalbi-Shtylik, Giel Hendriks, Himabindu Gali, Ayal Hendel, Fredrik Johansson, Klaus Erixon, Zvi Livneh, Leon H F Mullenders, Lajos Haracska, Niels de Wind
